Boston Scientific Resumes Most, Not All, Implantable Defibrillator Shipments
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific resumed shipments of virtually all of its implantable defibrillators April 15 following retrospective clearance by FDA of two manufacturing changes